Market share and costs of biologic therapies for inflammatory bowel disease in the USA. [electronic resource]
Producer: 20190312Description: 364-370 p. digitalISSN:- 1365-2036
- Administrative Claims, Healthcare -- statistics & numerical data
- Adolescent
- Adrenal Cortex Hormones -- economics
- Adult
- Biological Products -- economics
- Biological Therapy -- economics
- Child
- Child, Preschool
- Costs and Cost Analysis
- Databases, Factual
- Female
- Health Care Sector -- economics
- Humans
- Immunologic Factors -- economics
- Infant
- Infant, Newborn
- Inflammatory Bowel Diseases -- drug therapy
- Longitudinal Studies
- Male
- Mesalamine -- economics
- Retrospective Studies
- United States -- epidemiology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.